Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Esperion Theraptc (NQ: ESPR )

25.93 USD +0.48 (+1.89%)
Official Closing Price Updated: 7:39 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Esperion Theraptc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
SHAREHOLDER ALERT: ALGT ESPR FLEX PPG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
Pomerantz LLP announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ:ESPR) and certain of its officers. The class action, filed... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR
From ACCESSWIRE
ESPR NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important Upcoming Deadline in Class Action – ESPR
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ:ESPR) from February 22, 2017 through May 1, 2018, both dates inclusive... 
From GlobeNewswire News Releases
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
From ACCESSWIRE
Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. on Behalf of Investors
From ACCESSWIRE
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Molina Healthcare, Inc., Esperion Therapeutics, Inc., PPG Industries, Inc., Prothena Corporation, and Fl
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to... 
From GlobeNewswire News Releases
INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ:ESPR)... 
From GlobeNewswire News Releases
The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Molina Healthcare, Inc., Esperion Therapeutics, Inc., Kulicke and Soffa Industries, Inc., and PPG Industrie
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to... 
From GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
Pomerantz LLP announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ: ESPR) and certain of its officers. The class action, filed... 
From Business Wire News Releases
ESPR NOTICE: Pawar Reminds of Important July 6, 2018 Lead Plaintiff Deadline in Esperion Therapeutics, Inc. Class Action - ESPR
From ACCESSWIRE
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 – ESPR
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Esperion Therapeutics, Inc. Investors – ESPR
Kessler Topaz Meltzer & Check, LLP reminds Esperion Therapeutics, Inc. (Nasdaq:ESPR) (“Esperion”) investors that a class action lawsuit has been filed in the United States District Court for the... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
From ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR
From ACCESSWIRE
INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018
From ACCESSWIRE
ESPR NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
From ACCESSWIRE
Esperion Announces Late-Breaking Oral Presentation of Full Study 4 Results (1002-048) at the International Symposium on Atherosclerosis
Esperion (NASDAQ:ESPR) today announced that the full Phase 3 results from Study 4 (1002-048, also known as CLEAR Tranquility) were presented at the International Symposium on Atherosclerosis (ISA) in... 
From GlobeNewswire News Releases
The Klein Law Firm Reminds Investors of a Class Action on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Esperion Therapeutics, Inc. (NASDAQ:ESPR) who purchased shares between February 22, 2017 and May... 
From GlobeNewswire News Releases
ESPR WIRE NOTICE: Rosen Law Firm Announces Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ: ESPR) from February... 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
From ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR
From ACCESSWIRE
INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. - ESPR
From ACCESSWIRE
ESPR EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
Pomerantz LLP announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ: ESPR) and certain of its officers. The class action, filed... 
From Business Wire News Releases
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 – ESPR
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury Systems, I
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.